Stable anti-TNFR1 polypeptides, antibody variable domains & antagonists

Details for Australian Patent Application No. 2010311640 (hide)

Owner Glaxo Group Limited

Inventors De Silva, Inusha; Sepp, Armin; Stoop, Adriaan Allart

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010311640

PCT Pub. Number WO2011/051217

Priority 61/255,235 27.10.09 US

Filing date 25 October 2010

Wipo publication date 5 May 2011

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

10 May 2012 PCT application entered the National Phase

  PCT publication WO2011/051217 Priority application(s): WO2011/051217

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010311649-Apparatus and method for cooling and liquefying a fluid

2010311636-Process for the manufacture of organic compounds